BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3986804)

  • 1. In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins.
    Houghton JA; Houghton PJ; Hazelton BJ; Douglass EC
    Cancer Res; 1985 Jun; 45(6):2706-12. PubMed ID: 3986804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of vincristine complexes in cytosols derived from xenografts of human rhabdomyosarcoma and normal tissues of the mouse.
    Houghton JA; Williams LG; Houghton PJ
    Cancer Res; 1985 Aug; 45(8):3761-7. PubMed ID: 2990677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas.
    Houghton JA; Williams LG; Torrance PM; Houghton PJ
    Cancer Res; 1984 Feb; 44(2):582-90. PubMed ID: 6692363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard.
    Horton JK; Houghton PJ; Houghton JA
    Cancer Res; 1987 Dec; 47(23):6288-93. PubMed ID: 2890432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of guanine nucleotides on vincristine binding in tumor cytosols and purified tubulin: evidence for an inhibitor of vincristine binding.
    Bowman LC; Houghton JA; Houghton PJ
    J Cell Physiol; 1990 Sep; 144(3):376-82. PubMed ID: 2391373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered molecular properties of tubulin in a multidrug-resistant variant of Chinese hamster cells selected for resistance to vinca alkaloids.
    Pain J; Sirotnak FM; Barrueco JR; Yang CH; Biedler JL
    J Cell Physiol; 1988 Aug; 136(2):341-7. PubMed ID: 3045133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids.
    Houghton JA; Williams LG; Dodge RK; George SL; Hazelton BJ; Houghton PJ
    Biochem Pharmacol; 1987 Jan; 36(1):81-8. PubMed ID: 3541941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of resistance to vincristine in a childhood rhabdomyosarcoma growing in immune-deprived mice.
    Houghton JA; Houghton PJ; Brodeur GM; Green AA
    Int J Cancer; 1981 Oct; 28(4):409-15. PubMed ID: 7309287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of vincristine resistance in vincristine resistant human myelogenous leukemia K562.
    Tsuruo T; Oh-Hara T; Saito H
    Anticancer Res; 1986; 6(4):637-41. PubMed ID: 3463241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scheduling of vincristine: drug accumulation and response of xenografts of childhood rhabdomyosarcoma determined by frequency of administration.
    Houghton JA; Meyer WH; Houghton PJ
    Cancer Treat Rep; 1987; 71(7-8):717-21. PubMed ID: 3607783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of tubulin from parental and vincristine-resistant HOB1 lymphoma cells.
    Lee WP
    Arch Biochem Biophys; 1995 Jun; 319(2):498-503. PubMed ID: 7786033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
    Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study.
    Verrills NM; Liem NL; Liaw TY; Hood BD; Lock RB; Kavallaris M
    Proteomics; 2006 Mar; 6(5):1681-94. PubMed ID: 16456880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan.
    Friedman HS; Dolan ME; Kaufmann SH; Colvin OM; Griffith OW; Moschel RC; Schold SC; Bigner DD; Ali-Osman F
    Cancer Res; 1994 Jul; 54(13):3487-93. PubMed ID: 8012971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of 1-beta-D-arabinofuranosylcytosine resistance in human KB epidermoid carcinoma cells upon induction of a second resistance to vincristine.
    Sone S; Ishii K; Tsuruo T
    Cancer Res; 1986 Jun; 46(6):3099-104. PubMed ID: 3698026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristine.
    Conter V; Beck WT
    Cancer Treat Rep; 1984 Jun; 68(6):831-9. PubMed ID: 6539648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms.
    Sirotnak FM; Danenberg KD; Chen J; Fritz F; Danenberg PV
    Biochem Biophys Res Commun; 2000 Mar; 269(1):21-4. PubMed ID: 10694470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies with 4'-deoxyepivincristine (vinepidine), a semisynthetic vinca alkaloid.
    Mullin K; Houghton PJ; Houghton JA; Horowitz ME
    Biochem Pharmacol; 1985 Jun; 34(11):1975-9. PubMed ID: 4004913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.